Matches in Wikidata for { <http://www.wikidata.org/entity/Q64693180> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q64693180 description "clinical trial" @default.
- Q64693180 description "ensayu clínicu" @default.
- Q64693180 description "klinisch onderzoek" @default.
- Q64693180 description "клінічне випробування" @default.
- Q64693180 name "Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone" @default.
- Q64693180 type Item @default.
- Q64693180 label "Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone" @default.
- Q64693180 prefLabel "Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone" @default.
- Q64693180 P1050 Q64693180-9EAEFF61-FF15-48E9-9436-78764D2F4C73 @default.
- Q64693180 P1132 Q64693180-6A55CCA2-79F0-43A2-8B3A-97F00DF80BD3 @default.
- Q64693180 P1476 Q64693180-87D0CC70-B68D-4F0F-A80D-543CAEB4A970 @default.
- Q64693180 P17 Q64693180-15A5B901-013C-4AEC-ACEA-F6041ABC8263 @default.
- Q64693180 P17 Q64693180-9B98D262-81F9-4D42-8EED-A679E676A4BA @default.
- Q64693180 P17 Q64693180-9F136223-BB66-4D7B-86C5-61FD54E44BC6 @default.
- Q64693180 P17 Q64693180-F69B5968-9F61-4B85-9C04-AB5118ACE197 @default.
- Q64693180 P2899 Q64693180-0CFB6F20-1F42-4BEA-8A0A-2A4A3682B82E @default.
- Q64693180 P3098 Q64693180-3C584D80-E2CA-47BE-B0D5-66EF39F44D2D @default.
- Q64693180 P31 Q64693180-58833EB5-81B8-42D3-9D11-B5B1B82335F7 @default.
- Q64693180 P4135 Q64693180-27FF8A22-8F3C-4D42-9779-EDFDBAAA69C2 @default.
- Q64693180 P4844 Q64693180-6D02D6D6-B611-4E86-84C2-5CFAA14C9A7F @default.
- Q64693180 P4844 Q64693180-7C87C6A4-38B5-411B-B119-B51CBB0239D2 @default.
- Q64693180 P580 Q64693180-61C40AA1-4CC7-45EB-8370-573F8CECD299 @default.
- Q64693180 P582 Q64693180-28022EEB-D5AC-44F0-B68C-C58B509752F0 @default.
- Q64693180 P6099 Q64693180-05F0EE75-E9F1-4D3A-9739-C28FF5242D9D @default.
- Q64693180 P8363 Q64693180-55B55025-6EDE-4D5B-99AF-DAFC5707841B @default.
- Q64693180 P1050 Q12206 @default.
- Q64693180 P1132 "+278" @default.
- Q64693180 P1476 "A Phase III, Randomised, Double Blind, Placebo Controlled Parallel Group Efficacy and Safety Study of Linagliptin 5 mg Administered Orally Once Daily Over 24 Weeks in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite a Therapy of Metformin in Combination With Pioglitazone" @default.
- Q64693180 P17 Q142 @default.
- Q64693180 P17 Q30 @default.
- Q64693180 P17 Q668 @default.
- Q64693180 P17 Q928 @default.
- Q64693180 P2899 "+18" @default.
- Q64693180 P3098 "NCT00996658" @default.
- Q64693180 P31 Q30612 @default.
- Q64693180 P4135 "+79" @default.
- Q64693180 P4844 Q19484 @default.
- Q64693180 P4844 Q909745 @default.
- Q64693180 P580 "2009-10-01T00:00:00Z" @default.
- Q64693180 P582 "2012-03-01T00:00:00Z" @default.
- Q64693180 P6099 Q42824827 @default.
- Q64693180 P8363 Q78089383 @default.